Arthritis-Symptom.com
 

 

 

About Us

 

Arthritis Answers

Health News
64 condition specific health  news pages

Webmaster 

 

 
rheumatology.gif (2689 bytes)

August 2002

Cetylated Fatty Acids Improve Knee Function in Patients with Osteoarthritis

ROBERT HESSLINK Jr, DAVID ARMSTRONG III, M.V. NAGENDRAN, SRINAN SREEVATSAN, and RAJ BARATHUR

ABSTRACT.

Objective.
To determine the benefit of cetylated fatty acids (CFA) on knee range of motion and function in patients with osteoarthritis (OA).

Methods. Sixty-four patients with chronic knee OA were evaluated at baseline and at 30 and 68 days after consuming either placebo (vegetable oil; n = 31) or CFA (CeladrinTM; n = 33). Evaluations included physician assessment, knee range of motion with goniometry, and the Lequesne Algofunctional Index (LAI).

 
 

Results. After 68 days, patients treated with CFA exhibited significant (p < 0.001) increase in knee flexion (10.1) compared to patients given placebo (1.1). Neither group reported improvement in knee extension. Patient responses to the LAI indicated a significant (p < 0.001) shift towards functional improvement for the CFA group (-5.4 points) after 68 days compared to a modest improvement in the placebo group (-2.1 points).

Conclusion. Compared to placebo, CFA provides an improvement in knee range of motion and overall function in patients with OA of the knee. CFA may be an alternative to the use of nonsteroidal antiinflammatory drugs for the treatment of OA. (J Rheumatol 2002;29:1708-12)

Key Indexing Terms:

FATTY ACIDS
FISH OILS
OSTEOARTHRITIS
CETYL MYRISTOLEATE
5-LIPOXYGENASE

View the complete study here


 

From Hesslink Ventures and ClinCyte, San Diego, California, USA, and the Medical Center, Manipal, India.

Supported in part by a research contract awarded to ClinCyte by Imagenetix, Inc., San Diego, CA, USA.

R. Hesslink Jr, ScD; D. Armstrong III, PhD, Hesslink Ventures; M.V. Nagendran, MD, Medical Center, Manipal; S. Sreevatsan, PhD; R. Barathur, PhD, ClinCyte.

Address reprint requests to Dr. R. Hesslink Jr, PO Box 501691, San Diego, CA 92150.

Submitted July 27, 2001; revision accepted February 14, 2002.


 

 

 
 

 

 
This web site is intended for your own informational purposes only. No person or entity associated with this web site purports to be engaging in the practice of medicine through this medium. The information you receive is not intended as a substitute for the advice of a physician or other health care professional. If you have an illness or medical problem, contact your health care provider.